NPR: Temperature control in medicine delivery a rising risk

Consumers are used to getting what they need easily with the click of a button, including ordering and receiving their prescription medications through the mail. But those deliveries may be risky if medicines aren't stored and transported carefully, according to a report from NPR. 

Important medications are sometimes left outside of homes in the delivery process, exposing drugs to varying temperatures. For some patients, those actions can have consequences by impacting the effectiveness of a prescription.

In one such case in Arizona, a box of anti-rejection medications for a young boy, who had a liver transplant, was left outside the family’s garage for hours on a day when temperatures soared above 100 degrees, “well beyond the safe temperature range listed on the drug's guidelines,” NPR reported.

Shortly after, the boy’s body appeared to be rejecting the new organ, and the setback was enough for his mother to swear off mail-order pharmacy forever.

Despite the experiences shared by some consumers, online pharmacies maintain they provide temperature-controlled shipping and follow all FDA rules. Mail-order drugs are also a huge money-saver for pharmacy benefit managers, but scientists aren’t really sure how medicines are impacted by extreme temperatures, according to NPR.

The issue is getting attention as medicine delivery is becoming more widespread. E-commerce giant Amazon acquired online pharmacy PillPack in mid-2018 for approximately $1 billion. The prevalence of mail-order drugs could lead to expanded temperature control measures among pharmacies.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”